Scarica l'app Stockscreener
4.87
7.94%
-0.42
Dopo l'orario di chiusura:
4.59
-0.28
-5.75%
Rezolute Inc Borsa (RZLT) Ultime notizie
Institutional investors in Rezolute, Inc. (NASDAQ:RZLT) lost 11% last week but have reaped the benefits of longer-term growth - Simply Wall St
Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance
10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey
Rezolute's SWOT analysis: biotech stock eyes growth amid clinical progress - Investing.com India
We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully - Yahoo Finance
Rezolute stock soars to 52-week high, hits $6.1 amid surge By Investing.com - Investing.com South Africa
Rezolute stock soars to 52-week high, hits $6.1 amid surge - Investing.com India
(RZLT) Investment Report - Stock Traders Daily
Rezolute (NASDAQ:RZLT) Earns "Buy" Rating from HC Wainwright - MarketBeat
Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update - The Manila Times
Rezolute Advances Phase 3 Trials Despite $15.4M Loss; Maintains $117.8M Cash Position | RZLT Stock News - StockTitan
Equities Analysts Offer Predictions for Rezolute Q1 Earnings - MarketBeat
Wedbush Reaffirms “Outperform” Rating for Rezolute (NASDAQ:RZLT) - Defense World
Rezolute to Participate in Upcoming Investor Conferences - The Manila Times
Rezolute (NASDAQ:RZLT) Given Outperform Rating at Wedbush - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Average Price Target from Brokerages - MarketBeat
(RZLT) Technical Pivots with Risk Controls - Stock Traders Daily
SEC Form DEFA14A filed by Rezolute Inc. - Quantisnow
AAO 2024: Rezolute’s RZ-402 shows promising Phase IIa results in DME patients - Yahoo Finance
With 62% ownership, Rezolute, Inc. (NASDAQ:RZLT) boasts of strong institutional backing - Yahoo Finance
Cubist Systematic Strategies LLC Boosts Stock Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit - StockTitan
Renaissance Technologies LLC Sells 149,660 Shares of Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Shares Acquired by Cubist Systematic Strategies LLC - Defense World
Marshall Wace LLP Invests $4.50 Million in Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Continuing Rare Disease Treatment With A Compassionate Use Program (CUP) - Clinical Leader
Nantahala Capital Management LLC Cuts Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
XTX Topco Ltd Has $145,000 Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute's SWOT analysis: biotech firm's stock poised for growth amid clinical trials - Investing.com
Rezolute, Inc. (NASDAQ:RZLT) Short Interest Update - MarketBeat
Rezolute (NASDAQ:RZLT) Receives Buy Rating from HC Wainwright - MarketBeat
Rezolute Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
Rezolute Inc [RZLT] stock for 20,017 USD was acquired by Hogenhuis Wladimir - Knox Daily
Director Wladimir Hogenhuis Acquires 4,259 Shares of Rezolute In - GuruFocus.com
Affinity Asset Advisors LLC Acquires 250,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Affinity Asset Advisors LLC Purchases 250,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
Rezolute executive Wladimir Hogenhuis buys $20,017 in company stock By Investing.com - Investing.com Australia
Rezolute, Inc. (NASDAQ:RZLT) Director Wladimir Hogenhuis Buys 4,259 Shares - Defense World
Rezolute executive Wladimir Hogenhuis buys $20,017 in company stock - Investing.com
US FDA lifts partial clinical hold on Rezolute's low blood sugar treatment - MSN
BTIG bullish on Rezolute stock as pivotal trials move forward and hold lifted - Investing.com Canada
Rezolute Inc [RZLT] Director makes an insider acquire of 4,815 shares worth 19,982. - Knox Daily
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Misses Estimates By $0.14 EPS - Defense World
JMP Securities Reaffirms "Market Outperform" Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
JMP Securities Reiterates “Market Outperform” Rating for Rezolute (NASDAQ:RZLT) - Defense World
Rezolute (NASDAQ:RZLT) Releases Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Rezolute Inc (RZLT) stock analysis: A simple moving average approach - US Post News
Upward Trajectory: Rezolute Inc (RZLT) Posts a Slidee, Closing at 4.82 - The Dwinnex
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update - ForexTV.com
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides ... - The Bakersfield Californian
Rezolve AI Pops on Microsoft Investment - Baystreet.ca
Renaissance Technologies LLC Increases Stake in Embraer S.A. (NYSE:ERJ) - Defense World
Realbotix CEO Purchases Additional Common Shares in Open Market - Business Wire
RegTech deals projected to drop by a third for 2024 as investors focus on larger deals - FinTech Global
Zebra Technologies to showcase end-to-end AI solutions at VISION 2024 - Tahawul Tech
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):